Xenometrix offers excellence in the quality of products, services and support for fast, miniaturized and 3R-compliant bioassays, including the Ames test, miconucleus assay, the γH2AX/pH3 in vitro genotoxicity assay, the endocrine disruptor assays, skin absorption tests.

TEDD invites sponsors and exhibitors to actively participate in TEDD Annual Meeting 2019 on 24th October 2019 in Waedenswil, Switzerland. The Iinternational symposium will consist of invited expert talks, networking lunch with the exhibition of roughly 16-18 invited companies and Apéro. The conference is the most important event for TEDD partners, and each year we have a full house of 160+ participants. The professional yet relaxed atmosphere allows for excellent communication and exchange between all attendees.

At TEDD Annual Meeting 2019, we will discuss how stem cells have already been used in the drug discovery process and how novel technologies can be applied to attain widespread adoption of stem cell technology by the pharmaceutical and biotech industry.